246 related articles for article (PubMed ID: 29092077)
41. Historical changes and between-facility differences in adrenal venous sampling for primary aldosteronism in Japan.
Fujii Y; Takeda Y; Kurihara I; Itoh H; Katabami T; Ichijo T; Wada N; Shibayama Y; Yoshimoto T; Ogawa Y; Kawashima J; Sone M; Inagaki N; Takahashi K; Watanabe M; Matsuda Y; Kobayashi H; Shibata H; Kamemura K; Otsuki M; Yamamto K; Ogo A; Yanase T; Okamura S; Miyauchi S; Fujita M; Suzuki T; Umakoshi H; Ogasawara T; Tsuiki M; Naruse M;
J Hum Hypertens; 2020 Jan; 34(1):34-42. PubMed ID: 31462725
[TBL] [Abstract][Full Text] [Related]
42. Adrenal venous sampling as a diagnostic procedure for primary hyperaldosteronism: experience from a tertiary referral centre.
Salem V; Hopkins TG; El-Gayar H; Zac-Varghese S; Goldstone AP; Todd JF; Dhillo W; Field BC; Martin N; Hatfield E; Donaldson M; Palazzo F; Meeran K; Jackson J; Tan T
Hormones (Athens); 2012; 11(2):151-9. PubMed ID: 22801561
[TBL] [Abstract][Full Text] [Related]
43. Diagnostic Accuracy of Computed Tomography in Predicting Primary Aldosteronism Subtype According to Age.
Lee SH; Kim JW; Yoon HK; Koh JM; Shin CS; Kim SW; Kim JH
Endocrinol Metab (Seoul); 2021 Apr; 36(2):401-412. PubMed ID: 33789036
[TBL] [Abstract][Full Text] [Related]
44. The value of CT-based energy imaging to discriminate dominant side lesions in primary aldosteronism.
Huang M; Yang D; Zhang Y; Zhang Y; Mu Y
Front Endocrinol (Lausanne); 2023; 14():1121388. PubMed ID: 37124744
[TBL] [Abstract][Full Text] [Related]
45. 131I-6beta-iodomethyl-19-norcholesterol SPECT/CT for primary aldosteronism patients with inconclusive adrenal venous sampling and CT results.
Yen RF; Wu VC; Liu KL; Cheng MF; Wu YW; Chueh SC; Lin WC; Wu KD; Tzen KY; Lu CC;
J Nucl Med; 2009 Oct; 50(10):1631-7. PubMed ID: 19759122
[TBL] [Abstract][Full Text] [Related]
46. 11C-Metomidate PET-CT versus adrenal vein sampling to subtype primary aldosteronism: a prospective clinical trial.
Puar TH; Khoo CM; Tan CJ; Tong AKT; Tan MCS; Teo AE; Ng KS; Wong KM; Reilhac A; O'Doherty J; Gomez-Sanchez CE; Kek PC; Yee S; Tan AWK; Chuah MB; Lee DHM; Wang KW; Zheng CQ; Shi L; Robins EG; Foo RSY;
J Hypertens; 2022 Jun; 40(6):1179-1188. PubMed ID: 35703880
[TBL] [Abstract][Full Text] [Related]
47. Comparison of sequential versus simultaneous methods of adrenal venous sampling.
Carr CE; Cope C; Cohen DL; Fraker DL; Trerotola SO
J Vasc Interv Radiol; 2004 Nov; 15(11):1245-50. PubMed ID: 15525743
[TBL] [Abstract][Full Text] [Related]
48. Comparison of C-arm computed tomography and on-site quick cortisol assay for adrenal venous sampling: A retrospective study of 178 patients.
Chang CC; Lee BC; Chang YC; Wu VC; Huang KH; Liu KL;
Eur Radiol; 2017 Dec; 27(12):5006-5014. PubMed ID: 28677050
[TBL] [Abstract][Full Text] [Related]
49. The role of adrenal venous sampling and computed tomography in the management of primary aldosteronism.
Ma D; Liu X; Zeng L; Yuan P; Liu Z; Xie J; Yuan G; Wang S; Yu X; Yang Y; Xu A
J Hypertens; 2021 Feb; 39(2):310-317. PubMed ID: 32868641
[TBL] [Abstract][Full Text] [Related]
50. Modification of the protocol for selective adrenal venous sampling results in both a significant increase in the accuracy and necessity of the procedure in the management of patients with primary hyperaldosteronism.
Harvey A; Pasieka JL; Kline G; So B
Surgery; 2012 Oct; 152(4):643-9; discussion 649-51. PubMed ID: 22929402
[TBL] [Abstract][Full Text] [Related]
51. Is there a role for segmental adrenal venous sampling and adrenal sparing surgery in patients with primary aldosteronism?
Satoh F; Morimoto R; Seiji K; Satani N; Ota H; Iwakura Y; Ono Y; Kudo M; Nezu M; Omata K; Tezuka Y; Kawasaki Y; Ishidoya S; Arai Y; Takase K; Nakamura Y; McNamara K; Sasano H; Ito S
Eur J Endocrinol; 2015 Oct; 173(4):465-77. PubMed ID: 26194502
[TBL] [Abstract][Full Text] [Related]
52. A comparison of the performance of
Yin X; Ai K; Luo J; Liu W; Ma X; Zhou L; Xiang X; Su X; Wang Y; Li Y
Front Endocrinol (Lausanne); 2024; 15():1291775. PubMed ID: 38419957
[TBL] [Abstract][Full Text] [Related]
53. Optimum position of left adrenal vein sampling for subtype diagnosis in primary aldosteronism.
Umakoshi H; Wada N; Ichijo T; Kamemura K; Matsuda Y; Fuji Y; Kai T; Fukuoka T; Sakamoto R; Ogo A; Suzuki T; Tsuiki M; Naruse M;
Clin Endocrinol (Oxf); 2015 Dec; 83(6):768-73. PubMed ID: 26123796
[TBL] [Abstract][Full Text] [Related]
54. Development and validation of model for sparing adrenal venous sampling in diagnosing unilateral primary aldosteronism.
Song Y; Yang J; Shen H; Ng E; Fuller PJ; Feng Z; Hu J; Ma L; Yang Y; Du Z; Wang Y; Luo T; He W; Li Q; Wu FF; Yang S;
J Hypertens; 2022 Sep; 40(9):1692-1701. PubMed ID: 35881462
[TBL] [Abstract][Full Text] [Related]
55. The SPARTACUS Trial: Controversies and Unresolved Issues.
Beuschlein F; Mulatero P; Asbach E; Monticone S; Catena C; Sechi LA; Stowasser M
Horm Metab Res; 2017 Dec; 49(12):936-942. PubMed ID: 29165736
[TBL] [Abstract][Full Text] [Related]
56. [Comparison of adrenal imaging and selective adrenal vein sampling in primary hyperaldosteronism].
Vonend O; Stegbauer J; Kokulinsky P; Adams S; Liermann D; Hahn K; Rump LC
Dtsch Med Wochenschr; 2007 Nov; 132(46):2436-41. PubMed ID: 17987550
[TBL] [Abstract][Full Text] [Related]
57. Role of Aldosterone and Potassium Levels in Sparing Confirmatory Tests in Primary Aldosteronism.
Umakoshi H; Sakamoto R; Matsuda Y; Yokomoto-Umakoshi M; Nagata H; Fukumoto T; Ogata M; Ogawa Y
J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 31665338
[TBL] [Abstract][Full Text] [Related]
58. Primary hyperaldosteronism diagnosed with adrenal vein sampling. Characteristics and follow-up after adrenalectomy in a Danish study.
Pedersen M; Karlsen MA; Ankjærgaard KL; Jensen LT
Scand J Clin Lab Invest; 2016; 76(1):45-50. PubMed ID: 26471096
[TBL] [Abstract][Full Text] [Related]
59. Screening for unilateral aldosteronism should be combined with the maximum systolic blood pressure, history of stroke and typical nodules.
Meng Y; Chen K; Xie A; Liu Y; Huang J
Medicine (Baltimore); 2022 Oct; 101(43):e31313. PubMed ID: 36316930
[TBL] [Abstract][Full Text] [Related]
60. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 4: Subtype diagnosis.
Bardet S; Chamontin B; Douillard C; Pagny JY; Hernigou A; Joffre F; Plouin PF; Steichen O
Ann Endocrinol (Paris); 2016 Jul; 77(3):208-13. PubMed ID: 27036860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
